SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009382
Filing Date
2023-05-11
Accepted
2023-05-11 16:10:40
Documents
42
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20230331x10q.htm   iXBRL 10-Q 560559
2 EX-31 bpth-20230331xex31.htm EX-31 12488
3 EX-32 bpth-20230331xex32.htm EX-32 6285
  Complete submission text file 0001558370-23-009382.txt   2297520

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20230331.xsd EX-101.SCH 25600
5 EX-101.CAL bpth-20230331_cal.xml EX-101.CAL 20080
6 EX-101.DEF bpth-20230331_def.xml EX-101.DEF 65169
7 EX-101.LAB bpth-20230331_lab.xml EX-101.LAB 169979
8 EX-101.PRE bpth-20230331_pre.xml EX-101.PRE 141643
36 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20230331x10q_htm.xml XML 205622
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 23911091
SIC: 2834 Pharmaceutical Preparations